LIEPHARM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LIEPHARM
Largest movements
- Cash -€19,939
down €19,939 (-53.2%), from €37,453 to €17,514
mainly Contributions, distributions and other (-€160,000) and Debts after one year (-€19,832)
- Other debts +€95,058
up €95,058 (+30.3%), from €313,507 to €408,565
- Profit (loss) carried forward -€95,025
down €95,025 (-57.8%), from €164,402 to €69,377
- Debts after one year -€19,832
down €19,832 (-1.8%), from €1.1m to €1.1m
of which Financial debts: -€19,832
- Financial charges -€2,464
down €2,464 (-5.1%), from €48,035 to €45,572
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,654,011 | €1,634,071 | -€19,939 | -1.2% |
| Fixed assets | 21/28 | €1,566,557 | €1,566,557 | = | 0.0% |
| Financial fixed assets | 28 | €1,566,557 | €1,566,557 | = | 0.0% |
| Current assets | 29/58 | €87,453 | €67,514 | -€19,939 | -22.8% |
| Cash at bank and in hand | 54/58 | €37,453 | €17,514 | -€19,939 | -53.2% |
| Deferred charges and accrued income | 490/1 | €50,000 | €50,000 | = | 0.0% |
| Total equity and liabilities | 10/49 | €1,654,011 | €1,634,071 | -€19,939 | -1.2% |
| Equity | 10/15 | €214,402 | €119,377 | -€95,025 | -44.3% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €164,402 | €69,377 | -€95,025 | -57.8% |
| Amounts payable | 17/49 | €1,439,608 | €1,514,694 | +€75,086 | +5.2% |
| Amounts payable after more than one year | 17 | €1,080,442 | €1,060,609 | -€19,832 | -1.8% |
| Financial debts | 170/4 | €180,442 | €160,609 | -€19,832 | -11.0% |
| Other amounts payable | 178/9 | €900,000 | €900,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €358,993 | €453,928 | +€94,935 | +26.4% |
| Current portion of amounts payable after more than one year | 42 | €21,262 | €21,476 | +€214 | +1.0% |
| Trade debts | 44 | €2,015 | €2,081 | +€65 | +3.2% |
| Suppliers | 440/4 | €2,015 | €2,081 | +€65 | +3.2% |
| Taxes, remuneration and social security | 45 | €22,209 | €21,807 | -€402 | -1.8% |
| Taxes | 450/3 | €22,209 | €21,807 | -€402 | -1.8% |
| Other amounts payable | 47/48 | €313,507 | €408,565 | +€95,058 | +30.3% |
| Accrued charges and deferred income | 492/3 | €174 | €157 | -€17 | -9.7% |
| Other operating charges | 640/8 | €101 | - | -€101 | |
| Gross operating margin | 9900 | €127,534 | €126,790 | -€743 | -0.6% |
| Operating profit (loss) | 9901 | €127,433 | €126,790 | -€643 | -0.5% |
| Financial charges | 65/66B | €48,035 | €45,572 | -€2,464 | -5.1% |
| Recurring financial charges | 65 | €48,035 | €45,572 | -€2,464 | -5.1% |
| Profit (loss) for the period before taxes | 9903 | €79,397 | €81,218 | +€1,821 | +2.3% |
| Income taxes | 67/77 | €15,879 | €16,244 | +€364 | +2.3% |
| Profit (loss) for the period | 9904 | €63,518 | €64,975 | +€1,457 | +2.3% |
| Profit (loss) for the period to be appropriated | 9905 | €63,518 | €64,975 | +€1,457 | +2.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.